Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
21:33:11 EST Fri 23 Jan 2026
Enter Symbol
or Name
USA
CA



Q:MRNA - MODERNA INC - https://www.modernatx.com/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MRNA - Q0.948.50·48.575.748.71-3.075-5.919,919.7950,432130,30449.812  50.41  46.8455.19  22.2919:58:37Jan 2015 min RT 2¢

Recent Trades - Last 10 of 130304
Time ETExPriceChangeVolume
19:58:37Q48.58-3.29100
19:57:25Q48.59-3.2820
19:56:40Q48.52-3.357
19:55:58Q48.50-3.3721
19:55:24Q48.51-3.36100
19:54:41Q48.50-3.3750
19:54:13Q48.60-3.272
19:53:23Q48.51-3.361
19:49:59Q48.5115-3.35853
19:48:04Q48.50-3.3710

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-20 06:00U:MRNANews ReleaseModerna & Merck Announce 5-Year Data for Intismeran Autogene in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in the Primary Endpoint of Recurrence-Free Survival in Patients With High-Risk Stage III/IV Melanoma Following
2026-01-12 07:00U:MRNANews ReleaseModerna Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
2026-01-05 07:00U:MRNANews ReleaseModerna Announces Global Regulatory Submissions for Its Investigational Seasonal Influenza Vaccine
2025-12-18 07:00U:MRNANews ReleaseCEPI to Fund Pivotal Phase 3 Trial for Moderna's mRNA Pandemic Influenza Vaccine Candidate
2025-12-17 07:00U:MRNANews ReleaseModerna to Present at the 44th Annual J.P. Morgan Healthcare Conference
2025-12-15 07:00U:MRNANews ReleaseEMA Committee for Medicinal Products for Human Use Adopts Positive Opinion Recommending Authorization of Moderna's mNEXSPIKE (COVID-19 Vaccine, mRNA)
2025-12-12 10:47U:MRNANews ReleasePancreatic Cancer Survival Gains Accelerate as Novel Therapies Advance
2025-12-09 09:25U:MRNANews ReleaseGlobal AI Infrastructure Shift Ignites Biotech Growth Phase
2025-11-20 07:00U:MRNANews ReleaseModerna Secures $1.5 Billion Five-Year Credit Facility from Ares Management
2025-11-20 07:00U:MRNANews ReleaseModerna Analyst Day Highlights Pipeline Progress and Business Strategy Updates
2025-11-19 07:00U:MRNANews ReleaseModerna Expands U.S. Manufacturing with Onshoring of Drug Product Capabilities
2025-11-18 07:00U:MRNANews ReleaseModerna to Present at Upcoming Piper Sandler's 37th Annual Healthcare Conference on December 2, 2025
2025-11-06 07:00U:MRNANews ReleaseModerna Reports Third Quarter 2025 Financial Results and Provides Business Updates
2025-11-03 07:00U:MRNANews ReleaseModerna Announces First Patient Dosed in Phase 1/2 Study of Investigational T-Cell Engager for Multiple Myeloma
2025-10-23 14:43U:MRNANews ReleaseModerna Named a Top Employer by Science for Eleventh Consecutive Year
2025-10-23 07:00U:MRNANews ReleaseModerna to Host Investor Event - Analyst Day
2025-10-22 16:05U:MRNANews ReleaseModerna Announces Phase 3 Study of Investigational Cytomegalovirus (CMV) Vaccine Did Not Meet Primary Efficacy Endpoint
2025-10-19 08:00U:MRNANews ReleaseModerna Highlights Seasonal Flu and H5 Pandemic Flu Candidates at IDWeek 2025
2025-10-16 07:00U:MRNANews ReleaseModerna to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025